Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer
K. Huang, W.-S. Fan, X.-Y. Fu, Y.-L. Li, Y.-G. Meng Department of Obstetrics and Gynecology, Hanchuan People’s Hospital, Hanchuan, China.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer, by K. Huang, W.-S. Fan, X.-Y. Fu, Y.-L. Li, Y.-G. Meng, published in Eur Rev Med Pharmacol Sci 2019; 23 (6): 2353-2359. DOI: 10.26355/eurrev_201903_17379. PMID: 30964159” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadLong noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
K. Huang, W.-S. Fan, X.-Y. Fu, Y.-L. Li, Y.-G. Meng
Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 13
Pages: 7211-7211
DOI: 10.26355/eurrev_202007_21862